RB1 and neoplasm: This peptide’s development is rooted in the groundbreaking discovery that hyperphosphorylated RB functions as a potent suppressor of NF-κB activity and PD-L1 transcription, unveiling a previously unknown tumor suppressor role of RB (Burkhart and Sage, 2008).